Related Experiment Videos
[Inhibition of lymphocyte reactivity by pregnancy-associated serum factors]
Archives of Gynecology
|July 20, 1979
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
Breast cancer research and treatment·2020
Predictors of the course of quality of life during therapy in women with primary breast cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2017
Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients.
Archives of gynecology and obstetrics·2016
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation].
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2015
Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.
Archives of gynecology and obstetrics·2015
Key Informants' Perspectives on Accredited Breast Cancer Centres: Results of a Survey.
Geburtshilfe und Frauenheilkunde·2014
Vulval liposarcoma.
Archives of gynecology·1987
The measurement of amniotic fluid immunoglobulins by laser nephelometry.
Archives of gynecology·1987
Severe hypertensive reaction after naloxone injection during labor.
Archives of gynecology·1987
Surface morphology of the perfused rabbit ovary.
Archives of gynecology·1987
Instant effect of induced abortion on serum ceruloplasmin activity, copper and zinc levels.
Archives of gynecology·1987
Unilateral renal agenesis associated with ipsilateral blind vagina.
Archives of gynecology·1987
Correction: Skewed pulmonary innate immune cell composition underlies the delayed influenza clearance in aged mice.
Frontiers in microbiology·2026
Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression.
Frontiers in immunology·2026